Evidence map›Paper›PMID 26495116›Full record

ArticleJournal of nutritional science2015

Metabolism, health and fillet nutritional quality in Atlantic salmon (Salmo salar) fed diets containing n-3-rich microalgae.

Katerina Kousoulaki, Tone-Kari Knutsdatter Østbye, Aleksei Krasnov, Jacob Seilø Torgersen, Turid Mørkøre, John Sweetman

Open access · goldAbstract read
In one paragraph

Article in Journal of nutritional science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Review
  3. Inclusion of Ora-Pro-Nóbis (Veterinary sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Atlantic Salmon (Frontiers in physiology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Prospects on the Use ofFrontiers in microbiology · 2018
    Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Katerina KousoulakiNofima AS , Department of Nutrition and Feed Technology , N-5141 Fyllingsdalen , Norway.
Tone-Kari Knutsdatter ØstbyeNofima AS , Department of Nutrition and Feed Technology , N-5141 Fyllingsdalen , Norway.
Aleksei KrasnovNofima AS , Department of Nutrition and Feed Technology , N-5141 Fyllingsdalen , Norway.
Jacob Seilø TorgersenNofima AS , Department of Nutrition and Feed Technology , N-5141 Fyllingsdalen , Norway.
Turid MørkøreNofima AS , Department of Nutrition and Feed Technology , N-5141 Fyllingsdalen , Norway.
John SweetmanAlltech Inc. , Sarney , Dunboyne , County Meath , Republic of Ireland.
Nofima · NOFafo Foundation · NOAlltech (Ireland) · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microalgae, as primary producers of EPA and DHA, are among the most prominent alternative sources to fish oil for n-3 long-chain PUFA in animal and human nutrition. The present study aimed to assess technical, nutritional and fish health aspects of producing n-3-rich Atlantic salmon (Salmo salar) fish fillets by dietary supplementation of increasing levels of a DHA-producing Schizochytrium sp. and reduced or without use of supplemental fish oil. Atlantic salmon smolt were fed diets with graded levels of microalgae for 12 weeks, during which all fish showed high feed intake rates with postprandial plasma leptin levels inversely correlating with final mean fish body weights. Fish performance was optimal in all experimental treatments (thermal growth coefficient about 4·0 and feed conversion ratio 0·8-0·9), protein digestibility was equal in all diets, whereas dietary lipid digestibility inversely correlated with the dietary levels of the SFA 16 : 0. Fillet quality was good and similar to the control in all treatments in terms of n-3 long-chain PUFA content, gaping, texture and liquid losses during thawing. Histological fluorescence staining and immunofluorescence analysis of salmon intestines (midgut: base of intestine and villi) revealed significant effects on slime, goblet cell production and inducible nitric oxide synthase (iNOS) activity with increasing levels of dietary Schizochytrium sp. supplementation. Microarray analysis did not reveal any signs of toxicity, stress, inflammation or any other negative effects from Schizochytrium sp. supplementation in diets for Atlantic salmon.

Indexed as

0_ScYE, 0 g/kg Scizochytrium sp. + yeast extract (control)15_ScYE, 150 g/kg Scizochytrium sp. + yeast extract1_ScYE, 10 g/kg Scizochytrium sp. + yeast extract6_ScYE, 60 g/kg Scizochytrium sp. + yeast extractADC, apparent digestibility coefficientCK, creatine kinaseFAME, fatty acid methyl estersFarmed salmon fish fillet nutritional qualityFCR, feed conversion ratioiNOS, inducible nitric oxide synthaseISO, International Organization for StandardizationMicroalgaen-3 LC-PUFA, n-3 long-chain PUFAn-3 Long-chain PUFAScYE, Scizochytrium sp. + yeast extractTGC, thermal growth coefficient

Identifiers

PMID26495116
PMCPMC4611082
OpenAlexW2311401899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.